FK-779

N/A

Report date: 2024/12/06 10:45:04

Base Information

Drug NameFK-779
Drug Alias NameMNA-279X-910279HMR-1279FK-779
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydroorotate dehydrogenase inhibitors
TargetsDihydroorotate dehydrogenase
Therapy Area/IndicationsRejection of organ transplantationAutoimmune DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorth America
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi Aventis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi AventisAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune DiseasesMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A